General Practice · Hialeah, FL
NPI
1194762427
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
250 E 49th St
Hialeah, FL, 33013
Phone (305) 822-6885
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
3,227 services
Medicare patients, 2024
389
Average age 65
Drug cost, 2024
$1.7M
26,139 prescriptions
Company payments, 2025
$35.74
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Agustin Martinez was code 99490 (chronic, principal, and transitional care management), 1,267 times for 218 patients. In total Agustin Martinez billed 3,227 services in 23 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,267 | 218 | $52.82 | $67K |
| 99232 Hospital E&M - Subsequent | Facility | 797 | 118 | $67.46 | $54K |
| 99349 Home E&M - New and Established | Office | 264 | 100 | $105.83 | $28K |
| 99222 Hospital E&M - Initial | Facility | 212 | 115 | $113.00 | $24K |
| 99348 Home E&M - New and Established | Office | 146 | 75 | $62.54 | $9,130 |
| 99213 Office E&M - Established | Office | 101 | 42 | $71.80 | $7,252 |
| 99214 Office E&M - Established | Office | 90 | 42 | $101.21 | $9,109 |
| 99238 Hospital Discharge Management | Facility | 75 | 58 | $69.05 | $5,179 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 62 | 62 | $138.24 | $8,571 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 50 | 44 | $39.67 | $1,984 |
| 97550 Care Management/Coordination | Office | 26 | 24 | $43.97 | $1,143 |
| 82962 Clinical Chemistry | Office | 20 | 12 | $3.21 | $64.2 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 19 | 18 | $188.15 | $3,575 |
By year: 2022 $382K for 5,695 services; 2023 $260K for 3,950 services; 2024 $226K for 3,227 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 20 | 12 | $3.21 | $64.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Agustin Martinez prescribed most often to Medicare patients was Levothyroxine Sodium, with 932 prescriptions and refills. In total Agustin Martinez wrote 26,139 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 932 | 1,011 | 119 | $11K |
| Atorvastatin Calcium Generic | 878 | 1,008 | 140 | $12K |
| Lactulose Generic | 821 | 829 | 115 | $39K |
| Famotidine Generic | 774 | 841 | 118 | $7,653 |
| Lisinopril Generic | 707 | 777 | 93 | $5,578 |
| Pantoprazole Sodium Generic | 599 | 645 | 96 | $7,744 |
| Metformin Hcl Generic | 587 | 673 | 75 | $4,394 |
| Metoprolol Tartrate Generic | 580 | 618 | 75 | $4,077 |
| Gabapentin Generic | 562 | 595 | 86 | $6,464 |
| Amlodipine Besylate Generic | 560 | 627 | 82 | $3,251 |
| Montelukast Sodium Generic | 551 | 621 | 79 | $6,998 |
| Omeprazole Generic | 551 | 657 | 81 | $3,945 |
| Fenofibrate Fenofibrate Nanocrystallized | 538 | 636 | 73 | $18K |
| Eliquis Apixaban | 526 | 534 | 55 | $215K |
| Furosemide Generic | 519 | 541 | 86 | $3,177 |
Brand drugs: 3,422 claims; generic drugs: 22,495 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Agustin Martinez $35.74 ($35.74 in general payments such as food, travel and fees) from 5 companies. The largest payer was Kowa Pharmaceuticals America, Inc. with $20.
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Lilly USA, LLC LLY | 1 | $15.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.